Neuroprotection < Neuroprotective Agents < Neuropsychological Tests

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000091 (2000)	T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E Gross	Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000094 (2000)	A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. Moussaoui	The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000117 (2000)	C A Da Costa [France] ; K. Ancolio ; F. Checler	Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli.
000217 (2001)	O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. Féger	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000222 (2001)	S. Thobois [France] ; S. Guillouet ; E. Broussolle	Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
000223 (2002)	Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta Imperato	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000240 (2002)	Christelle Gouhier [France] ; Sylvie Chalon ; Anne Aubert-Pouessel ; Marie-Claire Venier-Julienne ; Christophe Jollivet ; Jean-Pierre Benoit ; Denis Guilloteau	Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
000256 (2002)	Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-Vozari	Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
000268 (2002)	Anne-Marie Bonnet [France]	[Alpha-2 adrenergic receptors and Parkinson's disease].
000289 (2003)	Olivier Rascol [France] ; C. Brefel-Courbon ; P. Payoux ; J. Ferreira	The management of patients with early Parkinson's disease.
000290 (2003)	Alim-Louis Benabid [France] ; Laurent Vercucil ; Abdelhamid Benazzouz ; Adnan Koudsie ; Stephan Chabardes ; Lorella Minotti ; Philippe Kahane ; Michèle Gentil ; Doris Lenartz ; Christian Andressen ; Paul Krack ; Pierre Pollak	Deep brain stimulation: what does it offer?
000346 (2003)	Erwan Bezard [France]	Neuroprotection for Parkinson's disease: a call for clinically driven experimental design.
000350 (2003)	Cristine Alves Da Costa [France] ; Eliezer Masliah ; Frédéric Checler	Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.
000439 (2004)	Wassilios Meissner [France] ; Michael P. Hill ; François Tison ; Christian E. Gross ; Erwan Bezard	Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.
000520 (2005)	Stéphane Thobois [France] ; Florence Delamarre-Damier ; Pascal Derkinderen	Treatment of motor dysfunction in Parkinson's disease: an overview.
000594 (2006)	Erwan Bezard [France] ; Irene Gerlach ; Rosario Moratalla ; Christian E. Gross ; Reinhard Jork	5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease.
000646 (2006)	Kathy Dujardin [France] ; David Devos ; Stéphane Duhem ; Alain Destée [France] ; Rose-Marie Marié ; Franck Durif ; Lucette Lacomblez ; Jacques Touchon ; Pierre Pollak ; Jean-Jacques Péré	Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
000652 (2006)	E C Hirsch [France]	How to judge animal models of Parkinson's disease in terms of neuroprotection.
000683 (2006)		Rasagiline. Parkinson's disease: a simple me-too.
000719 (2007)	Laïla Amazzal [France] ; Agnès Lapôtre ; Frédéric Quignon ; Denyse Bagrel	Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
000770 (2007)	Pierre Etienne Chabrier [France] ; Michel Auguet	Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Neuroprotective Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neuroprotective Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024